Lucintel Forecasts The Global Sonodynamic Therapy Market To Grow With A Cagr Of 12.3% From 2025 To 2031

By Author: Lucintel LLC
Total Articles: 7912
Comment this article

According to a market report by Lucintel, the future of the global sonodynamic therapy market looks promising with opportunities in the recurrent glioblastoma and diffuse intrinsic pontine glioma markets. The global sonodynamic therapy market is expected to grow with a CAGR of 12.3% from 2025 to 2031. The major drivers for this market are the increasing prevalence of cancer and the rising research & development in sonodynamic therapy.
A more than 150-page report to understand trends, opportunity and forecast in global sonodynamic therapy market to 2031 by type (device and drug), application (recurrent glioblastoma, diffuse intrinsic pontine glioma, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, device will remain larger segment over the forecast period due to primary role of ultrasound devices in sonodynamic therapy.
Within the application category, recurrent glioblastoma is expected to witness the higher growth due to high prevalence of cancer.
Download sample by clicking on sonodynamic therapy market
...
... In terms of region, North America is expected to witness the highest growth over the forecast period.
SonALAsense, Alpheus Medical, Photolitec, CureMetrix, Philips Healthcare are the major suppliers in the sonodynamic therapy market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Renal Replacement Therapy Market
Paraffin Physical Therapy Market
Palladium Silver Target Market
Pain Light Therapy Device Market
Network Video Encoder Market